Guangzhou Royal Lee Cancer Center is a tertiary oncology hospital facing international patients. In cooperation with Sun Yat-sen University Cancer center, it is now a JCl-accredited and platform-enabled hospital based in Southern China. More inspiringly, it has been an approved GCP (Good Clnical Practice) facility since September, 2022. To better meet the healthcare need of neayby communities, it has established extensive cooperatian with more than 40 major domestic and international commercial insurance companies. Located at Sino-Singapore Guangzhou Knowledge City in Huangpu District of Guangzhou, Royal Lee is outfitted with 400 beds and committed to providing high-quality cancer prevention, treatment and rehabilitation for all the clients.
Royal Lee has established multiple sophisticated tumor treatment systems featuring minimally invasive surgery coupled with conventional surgery radiotherapy, and chemotherapy, including Yttrum-90 microshpere, nanoknife, argon-helium cryosurgery, radioactive seed implants, cryoablation and proton therapy. In the aspect of rehabilitation, cancerous pain management is carried out by utilizing nutriology, psychology and Traditional Chinese Medicine to minimize the pain of tumor patients and prolong their survival duration. Furthermore, the hospital also offers a unique health management service tailored to the entire Iifecycle health needs, adopting a residential-style physical examination approach, with a focus on "early screening for tumors, chronic disease management, and body resillience," to meet the diverse health demands of customers both domestically and internationally.
